Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Belite Bio, Inc. Sponsored ADR (BLTE) had Normalized Pre-Tax Income of $-26.94M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-26.94M |
|
-- |
|
-- |
|
$32.68M |
|
$-32.68M |
|
$5.75M |
|
$-26.94M |
|
|
Normalized Pre-Tax Income |
$-26.94M |
$-26.94M |
|
$-26.94M |
|
$-26.94M |
|
$-26.94M |
|
$-32.68M |
|
$-32.68M |
|
39.87M |
|
39.87M |
|
$-0.68 |
|
$-0.68 |
|
| Balance Sheet Financials | |
$521.86M |
|
-- |
|
$289.41M |
|
$811.27M |
|
$15.48M |
|
-- |
|
-- |
|
$15.48M |
|
-- |
|
$795.79M |
|
$795.79M |
|
40.09M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
33.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3.39% |
|
-3.32% |
|
-3.39% |
|
$19.85 |
|
-- |
|
-- |
|